Updates in Biliary Tract Cancers

by Daneng Li, Ya-Han Zhang, Christiana J. Crook, Renuka V. Iyer
Published 2022-06-01

Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life

by Daneng Li, Sabrina Sedano, Rebecca Allen, Jun Gong, May Cho, Sunil Sharma
Published 2019-06-01

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma

by Jun Gong, Jeremy Chuang, May Cho, Kyra Toomey, Andrew Hendifar, Daneng Li
Published 2020-07-01

Patient Preferences for Unresectable Hepatocellular Carcinoma Treatments: A Discrete-Choice Experiment

by Daneng Li, Ruoding Tan, Sairy Hernandez, Norelle Reilly, Cooper Bussberg, Carol Mansfield
Published 2023-02-01

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations

by Patrick C. Lee, Andrew Hendifar, Arsen Osipov, May Cho, Daneng Li, Jun Gong
Published 2021-04-01

Treatment Sequencing Strategies in Advanced Neuroendocrine Tumors: A Review

by Aman Chauhan, Jaydira Del Rivero, Robert A. Ramirez, Heloisa P. Soares, Daneng Li
Published 2022-10-01

Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial

by Riad Salem, Daneng Li, Nicolas Sommer, Sairy Hernandez, Wendy Verret, Beiying Ding, Riccardo Lencioni
Published 2021-08-01

Proposed Implementation of a Patient-Centered Self-Assessment Tool for Patients with Neuroendocrine Tumors among Academic and Community Practice Sites: The City of Hope Model

by Christiana Joy Crook, Lisa Yen, Kathleen Ta, Misagh Karimi, Danny Nguyen, Richard T. Lee, Daneng Li
Published 2023-02-01

Defining MRI Superiority over CT for Colorectal and Neuroendocrine Liver Metastases

by Marc A. Attiyeh, Gautam K. Malhotra, Daneng Li, Saro B. Manoukian, Pejman M. Motarjem, Gagandeep Singh
Published 2023-10-01

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade

by Jun Gong, Andrew Hendifar, Richard Tuli, Jeremy Chuang, May Cho, Vincent Chung, Daneng Li, Ravi Salgia
Published 2018-10-01

Atezolizumab Plus Bevacizumab vs Sorafenib for Unresectable Hepatocellular Carcinoma: Results From Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial

by Daneng Li, Han Chong Toh, Philippe Merle, Kaoru Tsuchiya, Sairy Hernandez, Wendy Verret, Alan Nicholas, Masatoshi Kudo
Published 2022-07-01

Immunotherapy Updates in Advanced Hepatocellular Carcinoma

by Amisha Singh, Ryan J. Beechinor, Jasmine C. Huynh, Daneng Li, Farshid Dayyani, Jennifer B. Valerin, Andrew Hendifar, Jun Gong, May Cho
Published 2021-04-01

Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name?

by Andrew H. Nguyen, Michael P. O’Leary, James P. De Andrade, Philip H. G. Ituarte, Jonathan Kessler, Daneng Li, Gagandeep Singh, Sue Chang
Published 2021-02-01

Improving Care for Spanish-Speaking Older Adults with Breast Cancer: Feasibility, Reliability, and Validity of a Self-Administered Spanish Language Geriatric Assessment

by Enrique Soto-Perez-de-Celis, Jessica Vazquez, Heeyoung Kim, Can-Lan Sun, Kemeberly Charles, Ashley Celis, Vani Katheria, Daneng Li, William Dale, Mina S. Sedrak
Published 2021-05-01

Efficacy and Safety of Atezolizumab Plus Bevacizumab vs Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150

by Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann-Lii Cheng, Norelle Reilly, Alan Nicholas, Sairy Hernandez, Ning Ma, Philippe Merle, Riad Salem, Daneng Li, Valeriy Breder
Published 2024-06-01

Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results...

by Daneng Li, Yohann Loriot, Adam M. Burgoyne, James M. Cleary, Armando Santoro, Daniel Lin, Santiago Ponce Aix, Ignacio Garrido-Laguna, Ramu Sudhagoni, Xiang Guo, Svetlana Andrianova, Scott Paulson
Published 2024-01-01

730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or a...

by Yuman Fong, Amanda Seiz, Hirva Mamdani, Melissa Polasek, Daneng Li, Leslie Chong, Alexander I Spira, Jennifer Leddon, Seymour Fein, Nick Ede, Ursula McCurry, Sharon Yavrom, Giovanni Selvaggi
Published 2023-11-01

Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma

by Lucas W. Thornblade, Paul Wong, Daneng Li, Susanne G. Warner, Sue Chang, Mustafa Raoof, Jonathan Kessler, Arya Amini, James Lin, Vincent Chung, Gagandeep Singh, Yuman Fong, Laleh G. Melstrom
Published 2021-08-01

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

by Xuan Ge, Susan E. Yost, Jin Sun Lee, Paul H. Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Samuel Chung, Christina Yeon, Daphne Stewart, Daneng Li, Swapnil Rajurkar, George Somlo, Joanne Mortimer, James Waisman, Yuan Yuan
Published 2022-09-01

Strategies to Improve Participation of Older Adults in Cancer Research

by Jennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, William Dale, Sumanta K. Pal, Daphne Stewart, Shanmugga Subbiah, Linda D. Bosserman, Cary Presant, Tanyanika Phillips, Kelly Yap, Addie Hill, Geetika Bhatt, Christina Yeon, Mary Cianfrocca, Yuan Yuan, Joanne Mortimer, Mina S. Sedrak
Published 2020-05-01